Eli Lilly & Co. (LLY) Handily Beats Q1 EPS, Revs Expectations; Boosts FY12 EPS Outlook
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $0.92, $0.14 better than the analyst estimate of $0.78. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.35 billion.
Eli Lilly & Co. sees FY2012 EPS of $3.15-$3.30, versus the consensus of $3.18. Eli Lilly & Co. sees FY2012 revenue of (n/a).
Eli Lilly & Co. sees FY2012 EPS of $3.15-$3.30, versus the consensus of $3.18. Eli Lilly & Co. sees FY2012 revenue of (n/a).
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.